D-0837-2016 Class III Terminated
FDA drug recall D-0837-2016 was initiated by Bryant Ranch Prepack Inc. on Mar 25, 2016 and is designated Class III. Reason for recall: Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate release formulation. The recall status is terminated (terminated Aug 29, 2016). Affected quantity: 21 bottles (910 extended release tablets).
Recall details
- Product Type
- Drugs
- Report Date
- May 11, 2016
- Initiation Date
- Mar 25, 2016
- Termination Date
- Aug 29, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 21 bottles (910 extended release tablets)
Product description
Venlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet, a) 30-count bottle (NDC 636290-3324-2), b) 100-count bottle (NDC 63629-3324-6), Rx Only, Manufactured by Teva Pharmaceuticals USA, Inc. Packaged by Bryant Ranch.
Reason for recall
Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate release formulation.
Distribution pattern
Nationwide
Code information
Lot # 94983; Exp 10/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0837-2016
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026